Tag Archives: John Sedor

Pernix soars on absolutely no news; naturally, rumors of a takeout flourish

The News: Pernix Therapeutics Holdings Inc. (Nasdaq:PTX) was one of the week’s top gainers, rocketing $2.02, or 50%, to $6.33 Monday (May 8, 2017)–without a press release being issued, or other… Read more »